Mice that lack activity of αvβ6- and αvβ8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice
The arginine-glycine-aspartate (RGD)-binding integrins αvβ6 and αvβ8 activate latent TGFβ1 and TGFβ3 in vivo, but it is uncertain whether other RGD-binding integrins such as integrins αvβ5 and αvβ3 activate these TGFβ isoforms. To define the combined role of αvβ6- and αvβ8-integrin in TGFβ activatio...
Saved in:
Published in | Journal of cell science Vol. 122; no. 2; pp. 227 - 232 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
The Company of Biologists Limited
15.01.2009
Company of Biologists |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The arginine-glycine-aspartate (RGD)-binding integrins αvβ6 and αvβ8 activate latent TGFβ1 and TGFβ3 in vivo, but it is uncertain whether other RGD-binding integrins such as integrins αvβ5 and αvβ3 activate these TGFβ isoforms. To define the combined role of αvβ6- and αvβ8-integrin in TGFβ activation, we analyzed mice lacking function of both integrins by means of gene deletion and/or pharmacologic inhibition. Most Itgb6⁻/⁻;Itgb8⁻/⁻ embryos die at mid-gestation; those that survive develop cleft palate-as observed in Tgfb3⁻/⁻ mice. Itgb8⁻/⁻ mice treated with an anti-αvβ6-integrin antibody develop severe autoimmunity and lack Langerhans cells-similar to Tgfb1-null mice. These results support a model in which TGFβ3-mediated palate fusion and TGFβ1-mediated suppression of autoimmunity and generation of Langerhans cells require integrins αvβ6 and αvβ8 but not other RGD-binding integrins as TGFβ activators. |
---|---|
Bibliography: | Supplementary material available online at http://jcs.biologists.org/cgi/content/full/122/2/????/DC1 This work was funded by NIH grant R01 HL063786 and an Irma T. Hirschl Scholar Award from the Irma T. Hirschl/Monique Weill-Caulier Trusts (both to J.S.M.). We thank Paola Mita for help with Langerhans cell staining and Ezra Dweck for helpful discussions and technical assistance. Author for correspondence (e-mail: john.munger@nyumc.org) |
ISSN: | 0021-9533 1477-9137 |
DOI: | 10.1242/jcs.035246 |